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there is substantial evidence that palliative RT is effective 
with reported response rates varying from 50% to 100%, the 
optimal RT schedule is unclear. This study explores the 
current pattern of practice of palliative RT for bleeding 
tumors with regard to dose and fractionation schemes in the 
Netherlands.  
Materials and Methods: An internet based survey, including 
respondent characteristics, factors influencing the choice of 
RT schedules, expected effectiveness of RT and five patient 
case scenarios on hematemesis, hemoptysis, hematuria, 
rectal bleeding and vaginal bleeding were developed and sent 
to all members (radiation oncologists and residents) of the 
Dutch Society for Radiation Oncology. Descriptive statistics 
were used to evaluate the results 
Results: The response rate of the internet based survey was 
125/374 (34%), and included 103 radiation oncologists and 22 
residents, representing 20 out of 21 RT departments in the 
Netherlands. Factors that were most often reported with 
regard to influencing the chosen RT schedules were patient 
related factors, like performance status, prognosis, patient's 
comfort and patient's choice. Late toxicity and the 
availability of linear accelerators were less contributing to 
the chosen RT schedules. In the patient cases there was a 
wide range in preferred RT schedules, however the most 
often chosen schedules were: 1x 8 Gy for hematemesis 
(esophageal bleeding 37% 1x8 Gy and bleeding of the stomach 
34% 1x8 Gy), 1x8 Gy and 5x 4 Gy (resp. 31% and 30%) for 
hemoptysis, 5x4 Gy (39%) for hematuria and 5x5 Gy (41%) in 
case of rectal bleeding. In case of vaginal bleeding 1x8 Gy, 
5x4 Gy and 10-13x3 Gy all represented about 20% of chosen 
RT schedules. Brachytherapy was rarely chosen as the 
preferred technique. Most respondents expected a response 
rate of 70 to 80%, a quick response within a few weeks and a 
response duration lasting for several weeks to months.  
Conclusions: There is a large range in RT schedules used for 
the treatment of bleeding tumors in the Netherlands. Most 
often a single fraction was chosen (35% of all cases), followed 
by a 5-fraction schedule (30% of all cases). The choice of an 
RT schedule was mainly influenced by patient related 
factors. Further research concerning the effectiveness of the 
various schedules is recommended. 
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Purpose/Objective: Radiotherapy is an effective treatment 
for metastásica spinal cord compression (MSCC). It is unclear 
if it remains useful in patients with limited survival. This 
study analyzed the effect of radiotherapy for MSCC among 
patients with short life expectancy in an academic cancer 
center. 
Materials and Methods: A prospective evaluation of all 
patients diagnosed with MSCC and estimated short life 
expectancy by the Rades prognostic score that were treated 
with RT was conducted between February 2013 and August 
2014. Single 8 Gy fraction was recommended but the final 
decision to use multiple fraction was made by the treating 
physician. Pain, ambulatory status and sphincter control were 
recorded before and after RT and related to outcome. Pain 
relief was evaluated following the International Bone 
Metastases Consensus Working Party Guidelines. Ambulatory 
status was evaluated with the Frankel scale. Presence of 
bone fracture and spinal instability (SINS score) were 
recorded. 
Results: 56 patients were diagnosed with MSCC during this 
period and 44 were included in this analysis. 39% of patients 
had primary lung tumors and 52% had unfavourable 
histologies. 39% had bone fracture and spinal instability was 
present in 16%. 70% were treated with single 8 Gy fraction. 
31% did not complete RT treatment in the non-8 Gy cohort. 
Median overall survival was 1,4 months. Before RT, the mean 
± sd pain intensity score was 7±2. The proportion showing a 
pain response in the 8 Gy cohort was 35%, 23%, 14%, 0% at 2 
weeks, 1, 2 or 3 months post-RT while it was 15%, 0%, 0%, 0% 
in the non-8 Gy cohort. Towards death, pain intensity score 
decreased to 4 in responders (28%), whereas in non-
responders no change was observed. 61% (8 Gy) vs 46% (non-8 
Gy) were ambulatory before RT. Following RT, non-
ambulatory to ambulatory state occured in 10% (8 Gy) vs 18 % 
(non-8 Gy), whereas ambulatory progressed to non-
ambulatory in 7% (8 Gy) vs 18 % (non-8 Gy). 68% (8 Gy) vs 46% 
(non-8 Gy) maintained sphincter control before RT. Following 
RT, non-preserved to preserved state occurred in 10% (8 Gy) 
vs 18% (non-8 Gy), whereas preserved progressed to non-
preserved in 3.5% (8 Gy) vs 9% (non-8 Gy). Median survival 
was 1.9 (8 Gy) vs 0.8 (non-8 Gy) months for Rades group I, 
and 1.5 (8 Gy) vs 3 (non-8 Gy) months for Rades group II. 71% 
of patients in the 8 Gy cohort spent <5% of their remaining 
lifetime on treatment (81%, ≤10%; 6%, ≥25%) while 46% of 
patients in the non-8 Gy cohort spent ≥30% (15%, >80%; 23%, 
≤10%). 
Conclusions: Pain responded in about one third of patients 
diagnosed with MSCC and short life expectancy. When 
considering radiotherapy, single fractions should be 
preferred.  
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Purpose/Objective: Bone metastases are the most common 
cause of cancer pain requiring treatment. Radiotherapy (RT) 
is able to control symptoms up to 90% of cases. Many 
prospective and randomized trials have compared the 
effectiveness of shorter schedules in the treatments of 
